Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Goldenwell Biotech (GWLL) Gross Profit (2021 - 2025)

Goldenwell Biotech (GWLL) has disclosed Gross Profit for 5 consecutive years, with $25000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit changed N/A year-over-year to $25000.0, compared with a TTM value of $62415.0 through Sep 2025, up 43546.85%, and an annual FY2024 reading of $64.0, down 90.39% over the prior year.
  • Gross Profit was $25000.0 for Q3 2025 at Goldenwell Biotech, down from $37500.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $37500.0 in Q2 2025 and bottomed at -$85.0 in Q4 2024.
  • Average Gross Profit over 5 years is $6940.6, with a median of $646.0 recorded in 2021.
  • The sharpest move saw Gross Profit plummeted 216.44% in 2024, then surged 53471.43% in 2025.
  • Year by year, Gross Profit stood at $1416.0 in 2021, then skyrocketed by 1526.27% to $23028.0 in 2022, then plummeted by 99.68% to $73.0 in 2023, then tumbled by 216.44% to -$85.0 in 2024, then skyrocketed by 29511.76% to $25000.0 in 2025.
  • Business Quant data shows Gross Profit for GWLL at $25000.0 in Q3 2025, $37500.0 in Q2 2025, and -$85.0 in Q4 2024.